Sign up
Pharma Capital
Why invest in CDY?

Cellmid's Maria Halasz discussed growing revenue streams at Proactive's CEO Sessions

Maria Halasz discussed rapidly growing hair care sales at Proactive's CEO Sessions.
Cellmid's Maria Halasz with investors at Proactive's CEO Sessions
BigPicture
Maria Halasz, chief executive, presenting at Proactive's CEO Sessions

Cellmid's (ASX:CDY) chief executive, Maria Halasz, joined Proactive's CEO Sessions in Sydney on Tuesday 3rd October and Melbourne on Tuesday 4th October.

The company is growing revenues from sales of its hair care products in the U.S.

50% discount on all evolis products. The code Proinvestovs50 will be valid until 13th October 2017.

To claim the discount, put the code in at checkout and the payment amount will automatically be adjusted to 50%.

Please note this code will work on the www.evolisprofessional.com.au and www.evolisproducts.com.au websites for 1 week only.

ACCESS THE FULL PRESENTATION HERE


 



Register here to be notified of future CDY Company articles
View full CDY profile

Cellmid Ltd Timeline

View All

Related Articles

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.